If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 1 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Liposomes Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Amphotericin B Medicine & Life Sciences
Small Interfering RNA Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
Growth Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1982 2019

Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4

Villar-Prados, A., Wu, S., Court, K. A., Ma, S., LaFargue, C., Chowdhury, M. A., Engelhardt, M. I., Ivan, C., Ram, P., Wang, Y., Baggerly, K. A., Rodriguez-Aguayo, C., Lopez, G., Ming-Yang, S., Maloney, D. J., Yoshioka, M., Strovel, J. W., Roszik, J. & Sood, A. K., Feb 1 2019, In : Molecular cancer therapeutics. 18, 2, p. 421-436 16 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Small Interfering RNA
Therapeutics
Down-Regulation
Neoplasms

Presence of Circulating miR-145, miR-155, and miR-382 in Exosomes Isolated from Serum of Breast Cancer Patients and Healthy Donors

Gonzalez-Villasana, V., Rashed, M. H., Gonzalez-Cantú, Y., Bayraktar, R., Menchaca-Arredondo, J. L., Vazquez-Guillen, J. M., Rodriguez-Padilla, C., Lopez, G. & Resendez-Perez, D., Jan 1 2019, In : Disease markers. 2019, 6852917.

Research output: Contribution to journalArticle

Open Access
Exosomes
MicroRNAs
Tissue Donors
Breast Neoplasms
Nanoparticles

PRKRA/PACT expression promotes chemoresistance of mucinous ovarian cancer

Hisamatsu, T., McGuire, M., Wu, S., Rupaimoole, R., Pradeep, S., Bayraktar, E., Noh, K., Hu, W., Hansen, J. M., Lyons, Y., Gharpure, K. M., Nagaraja, A. S., Mangala, L. S., Mitamura, T., Rodriguez-Aguayo, C., Eun, Y. G., Rose, J., Bartholomeusz, G., Ivan, C., Lee, J-S. & 5 othersMatsuo, K., Frumovitz, M., Wong, K. K., Lopez, G. & Sood, A. K., Jan 1 2019, In : Molecular cancer therapeutics. 18, 1, p. 162-172 11 p.

Research output: Contribution to journalArticle

oxaliplatin
Ovarian Neoplasms
Small Interfering RNA
Platinum
Phosphotransferases

PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis

Rodriguez-Aguayo, C., Bayraktar, E., Ivan, C., Aslan, B., Mai, J., He, G., Mangala, L. S., Jiang, D., Nagaraja, A. S., Ozpolat, B., Chavez-Reyes, A., Ferrari, M., Mitra, R., Siddik, Z. H., Shen, H., Yang, X., Sood, A. K. & Lopez, G., Feb 1 2019, In : EBioMedicine. 40, p. 290-304 15 p.

Research output: Contribution to journalArticle

Dinoprostone
Cisplatin
Ovary
Carcinogenesis
Up-Regulation